Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SGMO - BioMarin's Hemophilia A Treatment: An Assessment

SGMO - BioMarin's Hemophilia A Treatment: An Assessment

Sangamo Therapeutics Inc.
  • BioMarin received a CRL last August which delayed approval by 2 years.
  • Other competitors may be catching up.
  • Yet, BioMarin is still the clear leader in targeting hemophilia A via gene therapy.

For further details see:

BioMarin's Hemophilia A Treatment: An Assessment
Stock Information
Company Name: Sangamo Therapeutics Inc.
Stock Symbol: SGMO
Market: NASDAQ
Website: sangamo.com
Menu
SGMO SGMO Quote SGMO Short SGMO News SGMO Articles SGMO Message Board
Get SGMO Alerts

News, Short Squeeze, Breakout and More Instantly...